Hemostatic Drugs

On this page

Hemostasis & Drug Classes - Bleeding Stoppers 101

  • Hemostasis: Body's response to stop bleeding via vasoconstriction, platelet plug, and coagulation cascade (fibrin clot).
  • Procoagulant Drug Classes (Promote Clotting):
    • Vitamin K: For factors II, VII, IX, X synthesis. These factors require $Ca^{2+}$ for activity.
    • Coagulation Factors: Factor VIII (Hemophilia A), Factor IX (Hemophilia B).
    • Antifibrinolytics: Tranexamic acid, EACA; prevent clot breakdown.
    • Desmopressin (DDAVP): ↑ Factor VIII & vWF release.
    • Topical Hemostatics: e.g., Thrombin.
Loading diagram…

⭐ Vitamin K is essential for activating clotting Factors II, VII, IX, and X by enabling them to bind calcium.

Systemic Hemostatics - System-Wide Savers

  • Vitamin K (Phytonadione)
    • Mechanism: Cofactor for γ-carboxylation of clotting Factors II, VII, IX, X (📌 Mnemonic: 1972), Protein C & S.
    • Uses: Warfarin reversal, hemorrhagic disease of newborn, deficiency states.
    • Route: PO, SC, slow IV (rapid IV → anaphylaxis). Onset: PO 6-12h, IV 1-2h.
    • Dose (warfarin reversal): 1-10 mg PO/IV.
  • Desmopressin (DDAVP)
    • Mechanism: ↑ von Willebrand Factor (vWF) & Factor VIII release from endothelium.
    • Uses: Mild Hemophilia A, Type 1 vWD, uremic bleeding, drug-induced platelet dysfunction.

    ⭐ Desmopressin is key for bleeding in mild Hemophilia A & Type 1 von Willebrand disease.

  • Ethamsylate
    • Mechanism: Enhances platelet adhesion, ↓ capillary bleeding & fragility.
    • Uses: Menorrhagia, capillary bleeding (e.g., ENT, dental).
  • Adrenochrome Monosemicarbazone (Carbazochrome)
    • Mechanism: Reduces capillary fragility & permeability.
    • Uses: Hematuria, retinal hemorrhage, purpura.
  • Thrombopoietin (TPO) Receptor Agonists
    • Examples: Romiplostim (SC), Eltrombopag (PO).
    • Mechanism: Stimulate megakaryopoiesis → ↑ platelet count.
    • Uses: Chronic Immune Thrombocytopenic Purpura (ITP).
    • ⚠️ Risk: Bone marrow fibrosis, thromboembolism.

Local Agents & Blood Products - Site-Specific Seals

  • Physical & Absorbable Hemostats:
    • Gelatin Sponge (Gelfoam®): Swells with blood, provides clotting matrix. Absorbed: 4-6 wks.
    • Oxidized Regenerated Cellulose (ORC) (Surgicel®): Forms artificial clot with Hb. Bacteriostatic. Low pH. Absorbed: 1-2 wks.
    • Microfibrillar Collagen (Avitene®): Attracts & activates platelets for aggregation. Apply dry.
  • Biologically Active Topical Agents:
    • Thrombin (Topical): Converts fibrinogen → fibrin. Bovine, human, or recombinant. ⭐
      Bovine thrombin can induce antibodies against Factor V & thrombin, risking severe coagulopathy.
    • Fibrin Sealants (Fibrin Glue):
      • Components: Fibrinogen, Thrombin, Factor XIII, CaCl₂ (often from plasma).
      • Action: Mimics final coagulation step, forms stable fibrin clot.
  • Other Local Measures:
    • Cyanoacrylate Adhesives (Dermabond®): Rapidly polymerize, strong tissue bond.
    • Styptics (Alum, Ferric salts, AgNO₃): Precipitate proteins, constrict vessels. Superficial bleeding.

Clinical Use & Adverse Effects - Procoagulant Pointers

  • Vitamin K: Warfarin OD, newborn hemorrhage. AE: IV anaphylaxis.
  • FFP: Multi-factor loss (DIC, liver), urgent warfarin reversal. AE: TRALI, volume overload.
  • Cryoprecipitate: Fibrinogen, FVIII/vWF source. AE: Less volume vs FFP.
  • Factor VIII/IX: Hemophilia A/B. AE: Inhibitors, thrombosis.
  • PCCs (II,VII,IX,X): Rapid warfarin reversal. AE: ⚠️ High thrombotic risk (MI, VTE).
  • Desmopressin (DDAVP): Mild Hemophilia A, Type 1 vWD. AE: Hyponatremia.
  • Antifibrinolytics (TXA, EACA): ↓Bleeding (surgery, trauma). AE: Thrombosis, GI upset.

    ⭐ TXA in trauma: give within 3 hours of injury to ↓mortality. (CRASH-2)​

High‑Yield Points - ⚡ Biggest Takeaways

  • Vitamin K is essential for hepatic synthesis of clotting factors II, VII, IX, X.
  • Tranexamic acid & EACA are antifibrinolytics; they inhibit plasminogen activation to plasmin.
  • Desmopressin (DDAVP) increases endothelial release of Factor VIII and von Willebrand Factor.
  • Protamine sulfate is the specific antidote for heparin, forming an inactive complex.
  • Recombinant Factor VIIa (rFVIIa) treats hemophilia A/B with inhibitors or Factor VII deficiency.
  • Cryoprecipitate & fibrinogen concentrate provide fibrinogen for deficiency states like afibrinogenemia.

Unlock the full lesson and continue reading

Signup to continue reading this lesson and unlimited access questions, flashcards, AI notes, and more

Scan to download app

Scan to download
UNLOCK FREE ACCESS

Practice Questions: Hemostatic Drugs

  1. 1. Which condition is most commonly associated with warfarin-induced skin necrosis?

    • A. Protein S deficiency
    • B. Protein C deficiency
    • C. Factor X deficiency
    • D. Factor VII deficiency
    • E. AT III deficiency
    Show answer

    Answer: B. Protein C deficiency

    Protein C deficiency - Protein C deficiency is the classic association because warfarin lowers Protein C rapidly before adequately reducing procoagulant clotting factors. - The resulting transient hypercoagulability promotes microthrombi formation in skin vessels, producing warfarin-induced skin necrosis. AT III deficiency - Antithrombin III deficiency causes a hypercoagulable state, but it is not the classic inherited predisposition associated with warfarin-induced skin necrosis. - Warfarin-related necrosis results from an early fall in Protein C activity, producing transient thrombosis rather than primarily reflecting reduced antithrombin activity. Factor VII deficiency - Factor VII deficiency impairs the extrinsic coagulation pathway and is associated with a bleeding tendency, not the thrombotic process causing skin necrosis. - Warfarin initially lowers Protein C more rapidly than procoagulant factors, unlike factor VII deficiency, which does not explain this adverse effect. Protein S deficiency - Protein S deficiency can increase thrombosis risk because Protein S is a vitamin K-dependent anticoagulant, so it is a plausible but less typical association. - The classic association is Protein C deficiency, because warfarin rapidly reduces Protein C activity and causes transient hypercoagulation with microthrombi formation. Factor X deficiency - Factor X deficiency is a bleeding disorder caused by impaired coagulation, making it inconsistent with the thrombotic mechanism of warfarin-induced skin necrosis. - Warfarin-induced necrosis reflects an early hypercoagulable state, whereas factor X deficiency predisposes to hemorrhage rather than microvascular thrombosis.

  2. 2. Thiamine is NOT used in which of the following biochemical reactions?

    • A. Lactate to pyruvate via dehydrogenation
    • B. Alpha-ketoglutarate to succinyl CoA
    • C. Transketolase-mediated two-carbon transfer
    • D. Branched-chain α-keto acid decarboxylation
    Show answer

    Answer: A. Lactate to pyruvate via dehydrogenation

    Lactate to pyruvate uses NAD+-dependent lactate dehydrogenase, not TPP, so it is the exception. Alpha-ketoglutarate to succinyl CoA requires TPP-dependent α-ketoglutarate dehydrogenase. Transketolase-mediated two-carbon transfer requires TPP in the non-oxidative pentose phosphate pathway. Branched-chain α-keto acid decarboxylation requires the TPP-dependent branched-chain α-keto acid dehydrogenase complex.

  3. 3. A child presents with a history of fractures, multiple petechiae, perifollicular hemorrhages, and gum bleeding. Which of the following enzyme defects is involved?

    • A. Tyrosinase
    • B. Prolyl hydroxylase
    • C. Alkaline phosphatase
    • D. Lysyl oxidase
    Show answer

    Answer: B. Prolyl hydroxylase

    Prolyl hydroxylase - Vitamin C (Ascorbic acid) is a necessary cofactor for Prolyl hydroxylase and Lysyl hydroxylase, which are essential for the hydroxylation of proline and lysine residues in procollagen. - Deficiency of Vitamin C leads to inactivation of this enzyme, resulting in unstable and defective collagen that causes vascular fragility (leading to petechiae and gum bleeding) and impaired bone matrix (resulting in fractures). Lysyl oxidase - Lysyl oxidase is required for the crucial cross-linking of collagen and elastin fibers, a process that relies on copper, not Vitamin C, as a main cofactor. - Reduced copper-dependent lysyl oxidase activity contributes to connective-tissue abnormalities in Menkes disease; it is not the vitamin C-dependent hydroxylation defect responsible for scurvy. Tyrosinase - Tyrosinase is the key enzyme in the biosynthesis of melanin from tyrosine. - A defect in Tyrosinase causes various forms of Albinism, characterized by lack of pigmentation in the skin, hair, and eyes, which is unrelated to the described hemorrhagic and skeletal findings. Alkaline phosphatase - Alkaline phosphatase (ALP) plays a vital role in bone mineralization by hydrolyzing pyrophosphate, preventing its inhibitory effect on calcification. - While important for bone health, ALP deficiency causes Hypophosphatasia, and it is not directly involved in the pathogenesis of structural collagen defects seen in Scurvy.

  4. 4. A 65-year-old man presents with bone pain, fatigue, and hypercalcemia. Bone marrow biopsy reveals 30% plasma cells, and skeletal survey shows lytic lesions. Which of the following is a prognostic marker for this patient?

    • A. Beta 2 glycoprotein I
    • B. Beta 2 transferrin
    • C. Alpha-fetoprotein
    • D. Beta 2 microglobulin
    Show answer

    Answer: D. Beta 2 microglobulin

    Beta 2 microglobulin - Beta 2 microglobulin is an established prognostic marker in multiple myeloma, with levels reflecting disease burden and renal function. - The marrow plasmacytosis, lytic lesions, and hypercalcemia support multiple myeloma, in which serum Beta 2 microglobulin contributes to prognostic staging. Beta 2 glycoprotein I - Beta 2 glycoprotein I is associated with antiphospholipid syndrome and contributes to autoimmune thrombosis assessment. - It is not an established prognostic marker for multiple myeloma or other monoclonal plasma-cell disorders. Beta 2 transferrin - Beta 2 transferrin is a specific marker found in cerebrospinal fluid and is used to identify CSF leaks. - It does not reflect myeloma tumor burden or provide prognostic information in monoclonal gammopathies. Alpha-fetoprotein - Alpha-fetoprotein is a marker used in hepatocellular carcinoma and certain germ-cell tumors, not an established multiple-myeloma prognostic marker.

  5. 5. Identify the knot?

    • A. Slip knot
    • B. Reef (square) knot
    • C. Surgeon's knot
    • D. Granny's knot
    Show answer

    Answer: C. Surgeon's knot

    Surgeon's knot uses a double initial throw followed by an opposing single throw; the additional initial wrap increases friction. Slip knot has a sliding configuration. Granny's knot uses successive throws in the same direction. Reef (square) knot uses opposing single throws without the additional initial wrap.

  6. 6. Laboratory monitoring of which of the following is desirable with low molecular weight heparin therapy in a patient with renal failure?

    • A. Activated partial thromboplastin time
    • B. Clotting time
    • C. Prothrombin time
    • D. Anti-Xa activity
    Show answer

    Answer: D. Anti-Xa activity

    Anti-Xa activity - Anti-Xa activity specifically reflects the predominant anticoagulant effect of LMWH, which inhibits factor Xa more strongly than thrombin. - LMWH is primarily renally cleared and may accumulate when renal function is severely reduced; anti-factor Xa measurement is therefore desirable to assess dosing and bleeding risk. Activated partial thromboplastin time - Activated partial thromboplastin time (aPTT) is primarily used to monitor unfractionated heparin, not low molecular weight heparin, because LMWH produces insufficient and unreliable prolongation of this test. - The relatively high anti-factor Xa-to-anti-IIa activity of LMWH means aPTT is not sensitive enough for therapeutic monitoring, particularly when renal impairment causes drug accumulation. Clotting time - Clotting time (CT) is an obsolete, nonspecific bedside test and does not provide reliable quantitative assessment of low molecular weight heparin activity. - Because LMWH requires a more specific measure in renal failure, CT cannot detect accumulation or guide dosing safely when hemorrhage risk is increased. Prothrombin time - Prothrombin time (PT) assesses the extrinsic coagulation pathway and is used mainly to monitor vitamin K antagonists such as warfarin, rather than heparin preparations. - LMWH activity is not reliably reflected by PT, so it cannot identify clinically important renal accumulation or provide appropriate therapeutic monitoring.

  7. 7. Which of the following cell types is NOT a precursor of erythrocytes?

    • A. Proerythroblast
    • B. Reticulocyte
    • C. Normoblast
    • D. Myeloblast
    Show answer

    Answer: D. Myeloblast

    Myeloblast - Myeloblasts are immature precursors of granulocytes, including neutrophils, eosinophils, and basophils, rather than erythrocytes. - They participate in granulopoiesis, not erythropoiesis; therefore, this is the cell type that is not an erythrocyte precursor. Proerythroblast - Proerythroblasts are the earliest recognizable precursors in the erythroid lineage, developing from the common myeloid progenitor. - They differentiate through successive erythroblast stages, ultimately producing mature erythrocytes; therefore, this option is an erythrocyte precursor. Reticulocyte - Reticulocytes are immature red blood cells containing residual ribosomal RNA, which produces their reticular staining appearance. - They mature into functional erythrocytes within approximately 1–2 days after release into circulation, so they are part of erythrocyte maturation. Normoblast - Normoblasts, or erythroblasts, are intermediate cells in erythropoiesis and include basophilic, polychromatophilic, and orthochromatic stages. - They undergo progressive hemoglobin synthesis, nuclear condensation, and eventual nuclear extrusion before forming mature erythrocytes.

  8. 8. Ximelagatran, withdrawn because of hepatotoxicity, was developed as which type of drug?

    • A. Fibrinolytic
    • B. Antifibrinolytic
    • C. Anticoagulant
    • D. Platelet inhibitor
    Show answer

    Answer: C. Anticoagulant

    Anticoagulant is correct because ximelagatran is a prodrug of melagatran, a direct thrombin inhibitor; ximelagatran was withdrawn because of hepatotoxicity. Fibrinolytic drugs promote breakdown of existing fibrin clots, which is not the action of melagatran. Antifibrinolytic drugs inhibit fibrin breakdown rather than inhibiting thrombin. Platelet inhibitor drugs primarily inhibit platelet activation or aggregation, whereas melagatran is classified as an anticoagulant acting on thrombin.

  9. 9. Which statement about transfusion-associated anaphylactic reactions is NOT correct?

    • A. Potentially life-threatening allergic reaction
    • B. First-line treatment with epinephrine
    • C. Typical association with IgG deficiency
    • D. Risk reduction with washed red cells
    Show answer

    Answer: C. Typical association with IgG deficiency

    Typical association with IgG deficiency is the incorrect statement; the classic association is severe IgA deficiency with anti-IgA antibodies, although transfusion anaphylaxis can have other causes. Risk reduction with washed red cells results from removal of residual plasma proteins in selected high-risk patients. Potentially life-threatening allergic reaction accurately describes anaphylaxis. First-line treatment with epinephrine is correct because epinephrine rapidly treats airway compromise and circulatory collapse.

  10. 10. A 34-year-old woman has Raynaud's phenomenon associated with systemic sclerosis (scleroderma). Which of the following is the most appropriate management for this condition?

    • A. warm clothing
    • B. ergotamine
    • C. beta-blocking drugs
    • D. calcium channel blockers (nifedipine)
    Show answer

    Answer: D. calcium channel blockers (nifedipine)

    calcium channel blockers (nifedipine) - This is secondary Raynaud’s phenomenon due to systemic sclerosis, where structural vascular changes cause more severe vasospasm and ischemia than in primary disease. - Nifedipine, a calcium channel blocker, produces peripheral vasodilation and is the first-line pharmacological treatment, reducing the frequency and severity of attacks. beta-blocking drugs - Beta-blockers can block β2-mediated vasodilation, leaving relatively unopposed α-adrenergic vasoconstriction and potentially worsening Raynaud’s attacks. - Therefore, beta-blockers are generally avoided in Raynaud’s phenomenon; a vasodilating calcium channel blocker is more appropriate when antihypertensive treatment is needed. warm clothing - Warm clothing and cold avoidance reduce exposure to triggers and are useful non-pharmacological measures for all forms of Raynaud’s phenomenon. - However, they are insufficient as sole treatment for systemic-sclerosis-associated disease, which commonly requires pharmacological vasodilation because of structural vasculopathy. ergotamine - Ergotamine is a potent vasoconstrictor, so it can intensify digital vasospasm and worsen ischemia in patients with Raynaud’s phenomenon. - Although used for migraine treatment, its vasoconstrictive action makes it inappropriate and potentially harmful in systemic-sclerosis-associated Raynaud’s.

Flashcards: Hemostatic Drugs

  1. 1. Rivaroxaban is a direct  factor Xa inhibitor.

    Show answer

    oral::route

  2. 2. Prostacyclin analogs (epoprostenol/iloprost) can cause decreased platelet _____ and are potent _____.

    Show answer

    aggregation · vasodilators

  3. 3. What drugs are used to reverse the effects of thrombolytics?_____ and _____

    Show answer

    aminocaproic acid · tranexamic acid

  4. 4. Treatment for disorders of fibrinolysis is _____, which blocks activation of _____

    Show answer

    aminocaproic acid · plasminogen

  5. 5. _____ is a concern when desmopressin is used in _____ disorders

    Show answer

    Tachyphylaxis · bleeding

  6. 6. _____ is a competitive _____ of _____

    Show answer

    Vorapaxar · antagonist · PAR-1

  7. 7. Immune thrombocytopenia can be treated with the TPO receptor agonists _____ and _____

    Show answer

    eltrombopag · romiplostim

  8. 8. _____ is considered superior to all other parenteral iron supplementation especially for _____ IDA.

    Show answer

    Ferric carboxymaltose · postpartum

  9. 9. Treatment of hemophilia A involves _____ plus recombinant _____

    Show answer

    desmopressin · factor VIII

Everything you need for Indian Medical PG prep

Get full Oncourse access with lessons, practice questions, flashcards and AI study tools.

GET STARTED FOR FREE
75% OFFLimited time offer
GET 75% OFF